title: Marginal costs of hospital-acquired conditions: information for priority-setting for patient safety programmes and research.
abstract: OBJECTIVE
  To estimate the relative inpatient costs of hospital-acquired conditions.
  
  
  METHODS
  Patient level costs were estimated using computerized costing systems that log individual utilization of inpatient services and apply sophisticated cost estimates from the hospital's general ledger. Occurrence of hospital-acquired conditions was identified using an Australian 'condition-onset' flag for diagnoses not present on admission. These were grouped to yield a comprehensive set of 144 categories of hospital-acquired conditions to summarize data coded with ICD-10. Standard linear regression techniques were used to identify the independent contribution of hospital-acquired conditions to costs, taking into account the case-mix of a sample of acute inpatients (n = 1,699,997) treated in Australian public hospitals in Victoria (2005/06) and Queensland (2006/07).
  
  
  RESULTS
  The most costly types of complications were post-procedure endocrine/metabolic disorders, adding AU$21,827 to the cost of an episode, followed by MRSA (AU$19,881) and enterocolitis due to Clostridium difficile (AU$19,743). Aggregate costs to the system, however, were highest for septicaemia (AU$41.4 million), complications of cardiac and vascular implants other than septicaemia (AU$28.7 million), acute lower respiratory infections, including influenza and pneumonia (AU$27.8 million) and UTI (AU$24.7 million). Hospital-acquired complications are estimated to add 17.3% to treatment costs in this sample.
  
  
  CONCLUSIONS
  Patient safety efforts frequently focus on dramatic but rare complications with very serious patient harm. Previous studies of the costs of adverse events have provided information on 'indicators' of safety problems rather than the full range of hospital-acquired conditions. Adding a cost dimension to priority-setting could result in changes to the focus of patient safety programmes and research. Financial information should be combined with information on patient outcomes to allow for cost-utility evaluation of future interventions.
authors: Faculty of Medicine and Dentistry, University of Alberta, Edmonton, Canada. terri.jackson@ualberta.ca
authors: Terri
authors: T
authors: Jackson
authors: Hong Son
authors: HS
authors: Nghiem
authors: David
authors: D
authors: Rowell
authors: Christine
authors: C
authors: Jorm
authors: John
authors: J
authors: Wakefield
mesh_terms: D001315:Australia; D006292:Health Priorities / Q000191:economics / Q000458:organization & administration*; D006302:Health Services Research / Q000458:organization & administration*; D017721:Hospital Costs; D006801:Humans; D011787:Quality of Health Care / Q000191:economics / Q000458:organization & administration*; D017751:Safety Management / Q000191:economics / Q000458:organization & administration*